FDA Investigator CDR Rochelle B Young, RPh, MSA

CDR Rochelle B Young, RPh, MSA has conducted inspections on 135 sites in 12 countries as of 01 Jun 2015. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
135
Last Inspection Date:
01 Jun 2015
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, India, Israel, United Kingdom of Great Britain and Northern Ireland, Italy, Poland, China, Japan, Germany, Netherlands, France
FDA Investigators that have inspected at least one site in common with CDR Rochelle B Young, RPh, MSA:
Adam S Freeman, Adetutu M Gidado, Aditi S Thakur, Alan P Kurtzberg, Alberto A Viciedo, Alicia K Mckinsey, Alla Dubrovsky, Allen F Hall, Amir Alavi, Ana Maria Osorio, MD, Anastasia I Onuorah, Anastasia M Shields, Andrei Perlloni, Andrew K Haack, PhD, Andrew W Harmon, Angel K Sandhu, Angela E Glenn, Anh M Lac, Anita Narula, PhD, Anna M Brannen, Annika M Niles, Arindam Dasgupta, PhD, Arlene M Badillo, Ashar P Parikh, Azza Talaat, Barbara M Frazier, Bernice F Hirsch, Bo Chi, PhD, Bonita S Chester, Brandy D Brown, Brandy N Lepage, Breena L D'ambrogi, Bruce H Mccullough, Bryan S Roddy, Candace Y Gomez Broughton, Candice C Mandera, Candido Torres, Carl A Huffman, III, Carl Lee, Carla J Lundi, Carolyn A Renshaw, Caryn M Everly, Caryn M Mcnab, Catherine J Laufmann, CDR Ileana Barreto Pettit, CDR Thomas R Berry, PPh, Celeste K Wong, Charanjeet Jassal, Charisse K Green, Charles R Bonapace, PhD, Chelsea N Sealey, Cheryl A Clausen, Christine M Whitby, CSO, Concepcion Cruz, Jr, Courtney N Long, Craig A Garmendia, Cynthia Jim, CSO, Daniel C Geffin, Daniel J Roberts, Daniel L Aisen, Darlene B Almogela, David A Lum, David G Eng, David R Heiar, Dawn C Olenjack, Deborah A Greco, Dennis Cantellops Paite, Devaughn Edwards, Diane L Raccasi, Dipesh K Shah, Djamila Harouaka, Doan T Nguyen, PharmD, Douglas A Campbell, Douglas C Kovacs, Dr. Abhijit Raha, PhD, Dr. Barbara D Paul, PhD, Dr. Carmelo Rosa, Dr. Chunchang Fang, Dr. Ralph M Bernstein, PhD, Dr. Robert C Horan, MD, Dr. Sriram Subramaniam, PhD, Dr. Zhou Chen (nmi), MD PhD, Dustin P Tran, Dustin R Abaonza, Edecia A Richards, Edwin Melendez, Eileen A Liu, Elizabeth Juarez, Elizabeth S Furukawa, Emal Wahab, Emmanuel Adu Gyamfi, PhD, Eric L Dong, BS, Eric W Anderson, Erika V Butler, Erin D Mccaffery, Erin L Mcfiren, Evelyn Wong, Farhana Khan, Felix Maldonado, Gabrielle J Swain, Gajendiran Mahadevan, PhD, Gayle S Lawson, Gene D Arcy, Gene R Gunn, George Pyramides, Gerald Mierle, Gerald N Mcgirl, DDS, Geraldine D Sanders, Gerardo Z Vazquez, German Rivera, Gina M Hall, Glen E Harelson, Greg K Keshishyan, Gregson A Joseph, Gwyn G Dickinson, Helen B Ricalde, Helen Verdel, Henry K Lau, Heriberto Negron Rivera, Humberto Z Gomez, Hung H Do, MS, Italia Nappi, Ivis L Negron, James A Lane, James C Lee, PharmD, James C Maclaughlin, James C Yee, James I Giefer, James R Evans, Jannifer L Degroot, Javier E Santos, Jeanne A Young, Jeanne J Thai, Jeffrey D Meng, Jeffrey M Watson, Jeffrey P Raimondi, Jeffrey W Shrifter, DPM, Jennifer Crumb, Jennifer L Degroot, Jennifer L Huntington, Jennifer L Johnson, Jennifer M Gogley, Joanne Hosting, Joey V Quitania, John A Gonzalez, John A Iwen, John D White, Jolanna A Norton, Jolene S Hedgecock, Jorge L Gonzalez, Jorge L Guadalupe, Jose A Lopez, Jose Acruz Gonzalez, Jose M Melendez, Joseph A Piechocki, Joseph A Seitz, III, Joseph Kutze, PhD, Joseph P Iser, MD, Joslyn K Brunelle, PhD, Jude C Dikes, Juliane Kjung Lau, Julie A Rorberg, Julie A Stocklin, June P Page, Justin A Boyd, Karen D Phung, Karen Takahashi, Kari M Johansen, Karlygash I Yermukan, Katherine Szestypalow, Kathryn E King, Kavita K Lalwani, Keith O Webber, PhD, Keith Webber, PhD, Kellia N Hicks, Kelvin Cheung, Kelvin X Sanders, Kenneth H Williams, Kenneth O Gee, PhD, Kevin A Gonzalez, Kevin D Kallander, Kevin P Foley, Kham Phommachanh, Kim Lthomas Cruse, Kouros Kangarli, Kristin M Abaonza, Kula N Jha, Lance Mde Souza, MBA, Latorie S Jones, Laura Fontan, MS, Laurie Graham, Lawton W Lum, LCDR Jennifer H Rhyu, Leiyun Boone, PhD, Leonard H Lavi, Li Hongpaul Yeh, PhD, Lija V Fellows, Lillie D Witcher, Liming Zhang, Linan Ha, PhD, Linda R Kuchenthal, Linda Thai, Linh Tu, Lisa R Hilliar, Lorna F Jones, Lucas B Leake, Lucila B Nwatu, Luis A Dasta, Lydia S Chan, Lynda L Perry, PhD, Maan S Abduldayem, Macropolk, Maida Henesian (NMI), Marcellinus D Dordunoo, Margaret A Smithers, Margaret M Annes, Maria Joselopez Barragan, PhD, Maridali Deleon Torres, Marie K Kinkade, Mariza M Jafary, Mark E Chan, Mark P Prusak, Mark W Babbitt, Marshalette O Edwards, Mary C Acton, Mary Ewilkerson Brinsko, Mary R Hole, Massoud Motamed, Mathew T Thomas, MD, Matthew B Casale, Matthew R Clabeaux, Matthew R Sleeter, Maxwell Van Tassell, PhD, Maxyne T Lam, Mei Chiung Huang (Jo), Meisha R Sampson, Meisha Waters, Melissa J Garcia, Melkamu Getie Kebtie, PhD, Michael A Charles, Michael D Kawalek, Michael J Kuchta, Michael L Casner, Michael R Goga, Michele L Obert, Michelle D Haamid, Michelle Rfrazier Jessen, PhD, Miguel A Martinez Perez, Mihaly S Ligmond, Milos Dokmanovic, PhD, Milva E Melendez Perales, Mohsen Rajabi Abhari, FDA, Monica M Mcclure, Monique C Lo, Mra Davism, Mra Mcculloughj, Mra Munizn, Muralidhara B Gavini, PhD, Myla D Chapman, Nadeem I Chaudhry, Natalia Pripuzova, PhD, Naveen B Walker, Nicholas L Hunt, Nicholas L Paulin, Nicola M Fenty Stewart, Noreen Muñiz, Nympha V Florendo, Omotunde O Osunsanmi, Parul M Patel, Patrice S Hall, Patricia F Hughes, PhD, Paul A Bonneau, Paul M Kawamoto, Paula A Trost, Peter E Baker, Prabhu P Raju, Prasad Peri, PhD, Pratik S Upadhyay, DDC, Qing Joanna Zhou, PhD, Ravi S Harapanhalli, Raymond T Oji, Rebecca Rodriguez, Reyes Candau Chacon, PhD, Richard E Needham, Robert C Steyert, Robert D Tollefsen, Robert M Barbosa, Robert R Wilson, Rowena S Nguyen, Rumany C Penn, PharmD, Russell K Riley, Ruth Moore, PhD, S Lori Brown, PhD MPH, Samantha J Pinizzotto, D V M, Samina S Khan, Samuel T Walker, Sandra A Hughes, Sandra S Saniga, Sangeeta M Khurana, PhD, Sarah A Hassas, Satheesh Thomas, Scott B Laufenberg, Scott N Lim, Scott T Ballard, Sergio Chavez (NMI), Seyyida Saterfield, Sharon K Thoma, PharmD, Sheri S Oliver, Sherri J Jackson, Sidney B Priesmeyer, Sneha S Patel, Sparky L Bartee, Sripal R Mada, PhD, Stephanie A Slater, MS, Stephen D Brown, Stephen D Eich, Stephen J Koniers, Stephen J Mottola, Steven E Porter, Jr, Steven Fong, MS, PhD, Steven M Weinman, Steven R Gillenwater, Stuart W Russell, Susanna E Ford, Taichun Qin, PhD, Tamara L Ely, Tamil Arasu, PhD, Teresa I Navas, Terrence Gee, Terri L Dodds, Terry A Hook, DPh, Thea C Grome, Theressa B Smith, Thomas J Arista, Thomas R Withers, Thomas W Gordon, Thomas W Nojek, Thuy T Nguyen, LCDR, Tiara Nbrown Crosen, Timothy C Grome, Torrance J Slayton, Towanda L Terrell, Truong Xuan Nguyen (Andy), Tsedenia Woldehanna, Uduak M Inokon, Unnee Ranjan, Uttaniti Limchumroon (Tom), Vaishali J Patel, Valerie L Whipp, Vanessa E Coulter, Walden H Lee, Wayne D Mcgrath, Wayne E Seifert, Wendy G Tan, PhD, William J Leonard, William V Millar, Xikui Chen (nmi), PhD, Yen Tso Kuo, Ying Xin Fan, PhD, Yiyue Zhang (nmi), PhD, Yumi J Hiramine, Yvesna C Blaise, Yvins Dezan, Zachary A Bogorad

CDR Rochelle B Young, RPh, MSA's Documents

Publish Date Document Type Title
March, 2003 FDA 483 SRI International - Form 483, 2003-03-12
May, 2001 EIR James D. Wolfe, M.D. - EIR, 2001-05-03
February, 2003 FDA 483 PPD Development LP - Form 483, 2003-02-20
February, 2001 EIR Marin Biologic - EIR, 2001-02-02
March, 2009 FDA 483 BioMarin Pharmaceutical Inc. - Form 483, 2009-03-20
November, 2002 EIR Alza Corp - EIR, 2002-11-01
May, 2004 EIR Eli Lilly and Company Limited - EIR, 2004-05-06
January, 2001 FDA 483 Instiutional Animal Care and Use Committee at UCSF - Form 483, 2001-01-26
July, 2003 EIR MedImmune, LLC - EIR, 2003-07-15
January, 2011 EIR BioZone Laboratories Inc. - EIR, 2011-01-31
February, 2001 FDA 483 Marin Biologic - Form 483, 2001-02-02
February, 2003 EIR Allergan Sales, LLC - EIR, 2003-02-20
November, 2000 FDA 483 Response St Mary'S Medical Center Irb - Form 483R, 2000-11-03
November, 2000 FDA 483 St Mary'S Medical Center Irb - Form 483, 2000-11-03
January, 2004 EIR Impax Laboratories, LLC. - EIR, 2004-01-29
February, 2002 FDA 483 Formulation Technology Incorporated - Form 483, 2002-02-07
April, 2003 EIR Pacific BioLabs - EIR, 2003-04-18
February, 2009 EIR Huashu Pharmaceutical Corporation - EIR, 2009-02-13
November, 2003 EIR Bay Bioanalytical Laboratory Inc - EIR, 2003-11-05
December, 2001 FDA 483 Prima Fleur Botanicals Inc - Form 483, 2001-12-20
July, 2003 FDA 483 BPR Health International - Form 483, 2003-07-09
August, 2002 EIR ALZA Corporation - EIR, 2002-08-08
January, 2001 EIR Instiutional Animal Care and Use Committee at UCSF - EIR, 2001-01-26
March, 2003 EIR SRI International - EIR, 2003-03-12
April, 2009 FDA 483 BioZone Laboratories, Inc - Form 483, 2009-04-28
November, 2000 EIR St Mary'S Medical Center Irb - EIR, 2000-11-03
February, 2000 EIR Rubin, Daniel L., M.D. - EIR, 2000-02-24
August, 2003 FDA 483 Hahnemann Laboratories, Inc. dba Alpine Pharmaceuticals - Form 483, 2003-08-11
November, 2010 EIR Kindeva Drug Delivery L.P. - EIR, 2010-11-05
August, 2003 EIR InterMune, Inc - EIR, 2003-08-27

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more